BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

FOLIGO THERAPEUTICS INC — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

FOLIGO THERAPEUTICS INC

via KSCW, INC.

4th Quarter (Oct 1 - Dec 31) · 2008Posted Jan 5, 2009Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: FOLIGO THERAPEUTICS INC
Description: A biotech firm working to develop early-stage DNA Therapeutics and Diagnostics
Location: Maryland · United States of America

Registrant

Firm: KSCW, INC.
Description: LOBBYING AND GOVERNMENT RELATIONS
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Funding for ovarian cancer research operations.
LobbyistsBILLY SENTER · DAVID SENTER · JOHN WEINFURTER · ADRIENNE HICKLE · LARRY MITCHELL · LISA MILES · BRIEN BONNEVILLE · mr JONATHAN J HARSCH
Covered position (JOHN WEINFURTER): Special Assistant, Rep. Tom Barrett
Covered position (LARRY MITCHELL): Deputy Admin. of Farm Programs - FSA, USDA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Small Business Administration (SBA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.